ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $99,338 | +15.6% | 11,250 | 0.0% | 0.02% | +16.7% |
| Q4 2022 | $85,950 | +7.4% | 11,250 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $80,000 | -12.1% | 11,250 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $91,000 | -71.2% | 11,250 | 0.0% | 0.02% | -64.4% |
| Q4 2021 | $316,000 | -17.3% | 11,250 | 0.0% | 0.06% | -24.4% |
| Q3 2021 | $382,000 | -70.7% | 11,250 | -65.3% | 0.08% | -72.3% |
| Q1 2021 | $1,304,000 | -48.6% | 32,388 | -24.5% | 0.28% | -55.1% |
| Q4 2020 | $2,538,000 | +63350.0% | 42,916 | -41.3% | 0.63% | -52.9% |
| Q3 2020 | $4,000 | -99.9% | 73,099 | -11.8% | 1.33% | +12.3% |
| Q2 2020 | $4,011,000 | +27.9% | 82,916 | -26.6% | 1.19% | +5.3% |
| Q1 2020 | $3,137,000 | – | 112,916 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |